TrialEuropean journal of cancer care2017

Efficacy and safety of fosaprepitant in the prevention of nausea and vomiting following highly emetogenic chemotherapy in Chinese people: A randomized, double-blind, phase III study.

L Q Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.